Your browser doesn't support javascript.
loading
RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1ß- and RNA-dependent co-activator of osteoclast gene expression.
Abe, Yohei; Kofman, Eric R; Almeida, Maria; Ouyang, Zhengyu; Ponte, Filipa; Mueller, Jasmine R; Cruz-Becerra, Grisel; Sakai, Mashito; Prohaska, Thomas A; Spann, Nathanael J; Resende-Coelho, Ana; Seidman, Jason S; Stender, Joshua D; Taylor, Havilah; Fan, Weiwei; Link, Verena M; Cobo, Isidoro; Schlachetzki, Johannes C M; Hamakubo, Takao; Jepsen, Kristen; Sakai, Juro; Downes, Michael; Evans, Ronald M; Yeo, Gene W; Kadonaga, James T; Manolagas, Stavros C; Rosenfeld, Michael G; Glass, Christopher K.
Afiliação
  • Abe Y; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Kofman ER; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA; Stem Cell Program, University of California San Diego, La Jolla, CA 92093, USA; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Almeida M; Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; Central Arkansas Veterans
  • Ouyang Z; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Ponte F; Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Mueller JR; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA; Stem Cell Program, University of California San Diego, La Jolla, CA 92093, USA; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Cruz-Becerra G; Department of Molecular Biology, University of California San Diego, La Jolla, CA 92093, USA.
  • Sakai M; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA; Biochemistry and Molecular Biology, Nippon Medical School Hospital, Tokyo 113-8602, Japan.
  • Prohaska TA; Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Spann NJ; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Resende-Coelho A; Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Seidman JS; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Stender JD; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Taylor H; Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Fan W; Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • Link VM; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA; Faculty of Biology, Department II, Ludwig-Maximilians Universität München, Planegg-Martinsried 82152, Germany.
  • Cobo I; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Schlachetzki JCM; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Hamakubo T; Department of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo 113-8602, Japan.
  • Jepsen K; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Sakai J; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 153-8904, Japan; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Downes M; Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • Evans RM; Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • Yeo GW; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA; Stem Cell Program, University of California San Diego, La Jolla, CA 92093, USA; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Kadonaga JT; Department of Molecular Biology, University of California San Diego, La Jolla, CA 92093, USA.
  • Manolagas SC; Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; Central Arkansas Veterans
  • Rosenfeld MG; Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Glass CK; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA; Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: ckg@ucsd.edu.
Mol Cell ; 83(19): 3421-3437.e11, 2023 10 05.
Article em En | MEDLINE | ID: mdl-37751740
ABSTRACT
The nuclear receptor co-repressor (NCoR) complex mediates transcriptional repression dependent on histone deacetylation by histone deacetylase 3 (HDAC3) as a component of the complex. Unexpectedly, we found that signaling by the receptor activator of nuclear factor κB (RANK) converts the NCoR/HDAC3 co-repressor complex to a co-activator of AP-1 and NF-κB target genes that are required for mouse osteoclast differentiation. Accordingly, the dominant function of NCoR/HDAC3 complexes in response to RANK signaling is to activate, rather than repress, gene expression. Mechanistically, RANK signaling promotes RNA-dependent interaction of the transcriptional co-activator PGC1ß with the NCoR/HDAC3 complex, resulting in the activation of PGC1ß and inhibition of HDAC3 activity for acetylated histone H3. Non-coding RNAs Dancr and Rnu12, which are associated with altered human bone homeostasis, promote NCoR/HDAC3 complex assembly and are necessary for RANKL-induced osteoclast differentiation in vitro. These findings may be prototypic for signal-dependent functions of NCoR in other biological contexts.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Osteoclastos / RNA Limite: Animals / Humans Idioma: En Revista: Mol Cell Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Osteoclastos / RNA Limite: Animals / Humans Idioma: En Revista: Mol Cell Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos